About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Oglemilast for the Treatment of Asthma

NCT00322686·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Forest Laboratories

Age

18–50

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Mild atopic asthma
Hyperreactivity to methacholine
Exhibit positive response to standard allergen skin prick test

You may not be if

Pulmonary disease other than asthma
Asthma exacerbation within 4 weeks
History of substance abuse
Active cardiac disease

The record

StatusCompleted

PhasePhase 2

Taking part6

StartedMay 2006

UpdatedMar 20, 2012

Conditions

Where1

Forest Investigative Site
Los Angeles, California, United States

Clareo Health | Study of Oglemilast for the Treatment of Asthma